Status:

COMPLETED

High Flow Therapy for the Treatment of Respiratory Failure in the ED

Lead Sponsor:

Vapotherm, Inc.

Collaborating Sponsors:

University of Texas

Memorial Hermann Texas Medical Center

Conditions:

Acute Respiratory Failure

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The overall objective of this study is to determine if Vapotherm high flow nasal cannula therapy (HFT), when used to treat respiratory failure in the ED, is at least equivalent to the current standard...

Eligibility Criteria

Inclusion

  • Adult patients (\> 18 yrs of age)
  • Presentation with acute respiratory failure according to the following criteria:
  • If any of these are present: Respiratory Rate \>22 or labored; Suspected Acute Respiratory Acidosis, as defined as pH \<7.32 on initial blood gas(either arterial or venous); Hypoxemia, as defined as Pulse Ox \<92%;
  • Clinical decision to escalate therapy to non-invasive ventilatory support, or to maintain non-invasive ventilatory support if delivered to the ED on such.

Exclusion

  • Suspected drug overdose
  • Cardiovascular instability as demonstrated by hypotension relative to initial clinical presentation that requires immediate intervention
  • End stage cancer
  • Life expectancy \< 6 months
  • Respiratory arrest or significant respiratory depression on presentation
  • Glasgow Coma Scale score \< 9
  • Cardiac arrest on initial presentation
  • Need for emergent intubation
  • Known or suspected cerebrovascular accident
  • Known or suspected ST segment elevation myocardial infarction
  • Patients with increased risk of pulmonary aspiration
  • Agitation or uncooperativeness

Key Trial Info

Start Date :

September 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2017

Estimated Enrollment :

204 Patients enrolled

Trial Details

Trial ID

NCT02236559

Start Date

September 1 2014

End Date

February 1 2017

Last Update

May 23 2019

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Athens Regional Medical Center

Athens, Georgia, United States, 30606

2

McLeod Regional Medical Center

Florence, South Carolina, United States, 29506

3

Erlanger Health System

Chattanooga, Tennessee, United States, 37403

4

Memorial Hermann Hospital

Houston, Texas, United States, 77030